EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Effectiveness of high‐dose esomeprazole or pantoprazole 10‐day sequential therapy empirically prescribed in Helicobacter pylori ‐infected naïve patients: a retrospective study

Matteo Pavoni, Giulia Fiorini, Angelo Zullo, Ilaria Maria Saracino, Luigi Gatta, Raffaele Manta, Andrea Imbrogno, Tiziana Lazzarotto, Claudio Borghi, Dino Vaira iD

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16731 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Matteo Pavoni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Esomeprazole, Helicobacter Infections, Helicobacter pylori, Pantoprazole. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Helicobacter pylori infection is one of the most common bacterial infections affecting humans, causing gastroduodenal and extraintestinal diseases. Treatment of the infection remains challenging for the clinicians, and different factors are involved in the failure of the therapeutic approach. The importance of the intensity of acid secretion inhibition remains an unclear issue. The aim of this study is to assess whether 80 mg/day esomeprazole‐based 10‐day sequential therapy (esomeprazole‐ST) achieved different eradication rates when compared to 80 mg/day pantoprazole‐based analogous regimen (pantoprazole‐ST).

Methods

This was a retrospective observational study where data of consecutive patients referred by their physicians to our unit to perform an upper gastrointestinal endoscopy were analyzed.

Results

Overall, 1,327 patients were available for the analysis: 599 and 728 patients received pantoprazole‐ST and esomeprazole‐ST, respectively. Eradication rate was significantly higher in patients receiving esomeprazole‐ST (92.6%, 95% CI: 91–94.5) than pantoprazole‐ST (89.3%, 95% CI: 86.7–91.7; difference: 3.3%; 95% CI: 0.2–6.5; P = 0.037). Even after a multivariate analysis, the esomeprazole‐ST achieved a significantly higher eradiation (OR: 1.44; 95% CI: 1.1–2.17).

Conclusions

This study showed that esomeprazole‐ST achieved significantly higher H. pylori cure rates than pantoprazole‐ST. Prospective and well‐designed trials are demander to confirm this prelaminar finding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EsomeprazoleHelicobacter InfectionsHelicobacter pyloriPantoprazoleProton Pump InhibitorsAdultAgedFemaleHumansMaleMiddle Aged2-PyridinylmethylsulfinylbenzimidazolesDrug Administration ScheduleRetrospective StudiesTime FactorsTreatment Outcome

Stichwörter der Autor:innen

H. pyloriPPIeradication ratesesomeprazolepantoprazolesequential therapy

Substanzen

2-PyridinylmethylsulfinylbenzimidazolesEsomeprazolePantoprazoleProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Cardiovascular Medicine Unit, Heart, Chest and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Gastroenterology and Digestive Endoscopy, Nuovo Regina Margherita Hospital, Rome, Italy.
  • Oncologic Screening Unit, ASL Toscana Nord-Ovest (ATNO), Carrara, Italy.
  • Digestive Endoscopy Unit, ASL Toscana Nord-Ovest (ATNO), "Spedali Riuniti" Hospital, Livorno, Italy.
  • Emergency Unit, Area Spoke, AUSL Bologna, Bologna, Italy.

ORCID-Profile: Dino Vaira

Zitieren

APA

Pavoni, M., Fiorini, G., Zullo, A., Saracino, I. M., Gatta, L., Manta, R., Imbrogno, A., Lazzarotto, T., Borghi, C., & Vaira, D. (2024). Effectiveness of high‐dose esomeprazole or pantoprazole 10‐day sequential therapy empirically prescribed in Helicobacter pylori ‐infected naïve patients: a retrospective study. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16731

Vancouver

Pavoni M, Fiorini G, Zullo A, Saracino IM, Gatta L, Manta R, et al. Effectiveness of high‐dose esomeprazole or pantoprazole 10‐day sequential therapy empirically prescribed in Helicobacter pylori ‐infected naïve patients: a retrospective study. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16731

BibTeX
@article{Pavoni2024,
  author = {Pavoni, Matteo and Fiorini, Giulia and Zullo, Angelo and Saracino, Ilaria Maria and Gatta, Luigi and Manta, Raffaele and Imbrogno, Andrea and Lazzarotto, Tiziana and Borghi, Claudio and Vaira, Dino},
  title = {Effectiveness of high‐dose esomeprazole or pantoprazole 10‐day sequential therapy empirically prescribed in Helicobacter pylori ‐infected naïve patients: a retrospective study},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16731}
}
Kostenlos starten →